APA

Wouters M., Dijkgraaf E. M., Kuijjer M. L., Jordanova E. S., Hollema H., Welters M., van der Hoeven J., Daemen T., Kroep J. R., Nijman H. W. & van der Burg S. H. (20210203). Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer. : Oncoimmunology.

Chicago

Wouters McA, Dijkgraaf E M, Kuijjer M L, Jordanova E S, Hollema H, Welters Mjp, van der Hoeven Jjm, Daemen T, Kroep J R, Nijman H W and van der Burg S H. 20210203. Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer. : Oncoimmunology.

Harvard

Wouters M., Dijkgraaf E. M., Kuijjer M. L., Jordanova E. S., Hollema H., Welters M., van der Hoeven J., Daemen T., Kroep J. R., Nijman H. W. and van der Burg S. H. (20210203). Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer. : Oncoimmunology.

MLA

Wouters McA, Dijkgraaf E M, Kuijjer M L, Jordanova E S, Hollema H, Welters Mjp, van der Hoeven Jjm, Daemen T, Kroep J R, Nijman H W and van der Burg S H. Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer. : Oncoimmunology. 20210203.